BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9490690)

  • 1. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
    Svenson M; Hansen MB; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
    Blood; 1998 Mar; 91(6):2054-61. PubMed ID: 9490690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.
    Wadhwa M; Meager A; Dilger P; Bird C; Dolman C; Das RG; Thorpe R
    Immunology; 2000 Jan; 99(1):113-23. PubMed ID: 10651949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid, accurate and robust particle-based assay for the simultaneous screening of plasma samples for the presence of five different anti-cytokine autoantibodies.
    Guldager DKR; von Stemann JH; Larsen R; Bay JT; Galle PS; Svenson M; Ullum H; Hansen MB
    J Immunol Methods; 2015 Oct; 425():62-68. PubMed ID: 26080061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity.
    Lopez AF; Eglinton JM; Lyons AB; Tapley PM; To LB; Park LS; Clark SC; Vadas MA
    J Cell Physiol; 1990 Oct; 145(1):69-77. PubMed ID: 1698795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for the carboxyl terminus of human granulocyte-macrophage colony-stimulating factor in the binding of ligand to the alpha-subunit of the high affinity receptor.
    Seelig GF; Prosise WW; Scheffler JE
    J Biol Chem; 1994 Feb; 269(8):5548-53. PubMed ID: 8119889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit.
    Brown CB; Pihl CE; Kaushansky K
    Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes.
    Elliott MJ; Vadas MA; Eglinton JM; Park LS; To LB; Cleland LG; Clark SC; Lopez AF
    Blood; 1989 Nov; 74(7):2349-59. PubMed ID: 2553163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.
    Hussain R; Kifayet A; Dojki M; Dockrell HM
    Immunology; 1999 Oct; 98(2):238-43. PubMed ID: 10540222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies.
    Urano S; Kaneko C; Nei T; Motoi N; Tazawa R; Watanabe M; Tomita M; Adachi T; Kanazawa H; Nakata K
    J Immunol Methods; 2010 Aug; 360(1-2):141-8. PubMed ID: 20621102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model.
    Hoang T; De Léan A; Haman A; Beauchemin V; Kitamura T; Clark SC
    J Biol Chem; 1993 Jun; 268(16):11881-7. PubMed ID: 8505314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF.
    Stomski FC; Dottore M; Winnall W; Guthridge MA; Woodcock J; Bagley CJ; Thomas DT; Andrews RK; Berndt MC; Lopez AF
    Blood; 1999 Sep; 94(6):1933-42. PubMed ID: 10477722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functionally distinct domains of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies.
    Kanakura Y; Cannistra SA; Brown CB; Nakamura M; Seelig GF; Prosise WW; Hawkins JC; Kaushansky K; Griffin JD
    Blood; 1991 Mar; 77(5):1033-43. PubMed ID: 1704802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.
    Lopez AF; Vadas MA; Woodcock JM; Milton SE; Lewis A; Elliott MJ; Gillis D; Ireland R; Olwell E; Park LS
    J Biol Chem; 1991 Dec; 266(36):24741-7. PubMed ID: 1761568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and binding kinetics of a soluble granulocyte-macrophage colony-stimulating factor receptor alpha-chain-Fc fusion protein.
    Monfardini C; Ramamoorthy M; Rosenbaum H; Fang Q; Godillot PA; Canziani G; Chaiken IM; Williams WV
    J Biol Chem; 1998 Mar; 273(13):7657-67. PubMed ID: 9516471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant antibodies in bioactive peptide design.
    Monfardini C; Kieber-Emmons T; VonFeldt JM; O'Malley B; Rosenbaum H; Godillot AP; Kaushansky K; Brown CB; Voet D; McCallus DE
    J Biol Chem; 1995 Mar; 270(12):6628-38. PubMed ID: 7896802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
    Heinzelman P; Carlson SJ; Cox GN
    Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.
    Budel LM; Elbaz O; Hoogerbrugge H; Delwel R; Mahmoud LA; Löwenberg B; Touw IP
    Blood; 1990 Apr; 75(7):1439-45. PubMed ID: 2156580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor.
    Urano S; Tazawa R; Nei T; Motoi N; Watanabe M; Igarashi T; Tomita M; Nakata K
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.